Apriem Advisors’s CVS Health CVS Stock Holding History

Apriem Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,178	Closed	-$236K	–	118
2019 Q4	$236K	Buy	+3,178	New	+$223K	0.05%	119
2018 Q3	–	Sell	-253	Closed	-$16K	–	188
2018 Q2	$16K	Buy	+253	New	+$16.7K	﹤0.01%	375
2017 Q2	–	Sell	-396	Closed	-$31K	–	218
2017 Q1	$31K	Buy	396 +75	+23%	+$5.99K	0.01%	285
2016 Q4	$25K	Buy	321 +58	+22%	+$4.69K	0.01%	315
2016 Q3	$23K	Sell	263 -100	-28%	-$9.44K	0.01%	309
2016 Q2	$35K	Buy	363 +100	+38%	+$9.97K	0.01%	265
2016 Q1	$27K	Buy	263 +23	+10%	+$2.24K	0.01%	270
2015 Q4	$23K	Hold	240	–	–	0.01%	281
2015 Q3	$23K	Hold	240	–	–	0.01%	274
2015 Q2	$25K	Hold	240	–	–	0.01%	292
2015 Q1	$25K	Hold	240	–	–	0.01%	287
2014 Q4	$23K	Hold	240	–	–	0.01%	276
2014 Q3	$19K	Sell	240 -4,059	-94%	-$320K	0.01%	306
2014 Q2	$324K	Buy	4,299 +240	+6%	+$18.1K	0.12%	91
2014 Q1	$304K	Hold	4,059	–	–	0.12%	95
2013 Q4	$291K	Hold	4,059	–	–	0.11%	90
2013 Q3	$230K	Hold	4,059	–	–	0.1%	98
2013 Q2	$232K	Buy	+4,059	New	+$235K	0.11%	92

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Apriem Advisors's CVS Position: Q1 2020 in Review

Apriem Advisors sold out of CVS Health (CVS) in Q1 2020, closing a stake of 3,178 shares — an estimated $236K sold.

Apriem Advisors first reported a position in CVS in Q2 2013 and held it in 18 quarters. The position peaked at $324K in Q2 2014. 1,817 funds tracked by Wall St. Rank hold CVS as of Q1 2020.

Apriem Advisors reported no remaining CVS Health position as of Q1 2020 after selling out during the quarter.
Apriem Advisors sold 3,178 CVS Health shares in Q1 2020, an estimated $236K.
Apriem Advisors first reported a position in CVS Health in Q2 2013 and held it in 18 quarters.
Apriem Advisors's CVS Health position peaked at $324K in Q2 2014.
1,817 funds tracked by Wall St. Rank held CVS Health as of Q1 2020.

Based on Apriem Advisors's 13F filing for Q1 2020, filed 7 May 2020.